Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

This activity includes Pharmacy SoundScripts audio narration.

Program Description

Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus that can substantially impact patients' quality of life. Early diagnosis and intervention are critical for mitigating the clinical burden of EoE and improving long-term prognosis. This supplement to The American Journal of Managed Care® reviews recent advances in the treatment of EoE, focusing on the potential of recently approved therapies to improve patient outcomes. Data from recent clinical trials and updated guideline recommendations highlight the progress made in targeting the histology and symptomatology of the disease. Important managed care considerations, including financial challenges and treatment access issues, that arise from the introduction of these novel therapies will be examined. Pharmacists and managed care professionals will gain insights into the inflammatory process of EoE and the importance of early treatment while optimizing health care resource utilization. The article provides an analysis of clinical data to support the safe and effective use of new therapies, as well as potential opportunities for improving treatment decision-making and resource allocation in the management of EoE.

Target audience: Managed care pharmacists

Type of activity: Application
Release date: August 23, 2024
Expiration date: August 23, 2025

Time to complete activity: 1.0 hour

Learner level: Foundational, Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine the inflammatory process of eosinophilic esophagitis (EoE) and the value of early diagnosis and treatment to mitigate the clinical burden of disease.
• Analyze the clinical data and for the safe and appropriate use of new and emerging therapies that target the histology and symptomology of EoE.
• Investigate managed care interventions that promote timely and appropriate access to treatment and reduce health care resource utilization in the treatment of EoE.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-24-220-H01-P. The activity is available for CE credit through August 23, 2025.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Faculty

Maureen Bauer, MD, has the following relevant financial relationships with commercial interests to disclose: Consultant (advisory board): Sanofi; Grant/Research (honoraria): Sanofi

Stephanie Spence, PharmD, CSP, has no relevant financial relationships with commercial interests to disclose.

Medical Writing & Editorial Support

Kelsey Giara, PharmD, RPh; and Elenna Smalley, PharmD, BCPS, have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Rose Buszka, PharmD, BCPS, CHCP; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

Medical reviewer Amanda Williams, PharmD, has the following relevant financial relationship with a commercial interest to disclose: Employee of a PBM

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms